checkAd

     241  0 Kommentare Aequus Reports Second Quarter 2023 Financial Highlights and General Update - Seite 3

    On behalf of the Board of Directors,

    “Douglas Janzen”
    Director & CEO

    CONTACT INFORMATION
    Aequus Investor Relations
    Email: investors@aequuspharma.ca
    Phone: 604-336-7906

    Lesen Sie auch

    Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this news release.



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Aequus Reports Second Quarter 2023 Financial Highlights and General Update - Seite 3 VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) - Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing, and promoting …